Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Hodson

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Science (New York, N.Y.)|April 23, 2016
RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescenceAlison Galloway, Alexander Saveliev, Sebastian Łukasiak, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2016
Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphomaLixin Rui, Amanda C Drennan, Michele Ceribelli, et al.
Blood|March 19, 2020
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network reportStuart E Lacy, Sharon L Barrans, Philip A Beer, et al.
Blood Advances|April 1, 2022
Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research NetworkSimon Crouch, Daniel Painter, Sharon L Barrans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2025
Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (CAPITAL)Daniel J Hodson, Geoffrey Shouse, Ho-Jin Shin, et al.
Nature Communications|October 20, 2022
Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escapeMaurizio Mangolini, Alba Maiques-Diaz, Stella Charalampopoulou, et al.
Blood Advances|September 8, 2020
PI3Kδ inhibition reshapes follicular lymphoma-immune microenvironment cross talk and unleashes the activity of venetoclaxNeus Serrat, Martina Guerrero-Hernández, Alba Matas-Céspedes, et al.
Cancer Discovery|April 29, 2024
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell LymphomaSean R Corcoran, James D Phelan, Jaewoo Choi, et al.
Nature Communications|September 23, 2018
Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemiaMaurizio Mangolini, Frederik Götte, Andrew Moore, et al.
Blood Advances|March 3, 2023
Cytokine receptor IL27RA is an NF-κB-responsive gene involved in CD38 upregulation in multiple myelomaRebecca J Brownlie, Ruth Kennedy, Erica B Wilson, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Science (New York, N.Y.)|April 23, 2016
RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescenceAlison Galloway, Alexander Saveliev, Sebastian Łukasiak, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2016
Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphomaLixin Rui, Amanda C Drennan, Michele Ceribelli, et al.
Blood|March 19, 2020
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network reportStuart E Lacy, Sharon L Barrans, Philip A Beer, et al.
Blood Advances|April 1, 2022
Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research NetworkSimon Crouch, Daniel Painter, Sharon L Barrans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2025
Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (CAPITAL)Daniel J Hodson, Geoffrey Shouse, Ho-Jin Shin, et al.
Nature Communications|October 20, 2022
Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escapeMaurizio Mangolini, Alba Maiques-Diaz, Stella Charalampopoulou, et al.
Blood Advances|September 8, 2020
PI3Kδ inhibition reshapes follicular lymphoma-immune microenvironment cross talk and unleashes the activity of venetoclaxNeus Serrat, Martina Guerrero-Hernández, Alba Matas-Céspedes, et al.
Cancer Discovery|April 29, 2024
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell LymphomaSean R Corcoran, James D Phelan, Jaewoo Choi, et al.
Nature Communications|September 23, 2018
Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemiaMaurizio Mangolini, Frederik Götte, Andrew Moore, et al.
Blood Advances|March 3, 2023
Cytokine receptor IL27RA is an NF-κB-responsive gene involved in CD38 upregulation in multiple myelomaRebecca J Brownlie, Ruth Kennedy, Erica B Wilson, et al.
Pageof 6